Stock Events

Stock Events

Carmat

€0.099000

106

-€0.00-1% Wednesday 15:30

Statistics

Day High

0.11

Day Low

0.0962

52W High

0.95

52W Low

0.085

Volume

807,348

Avg. Volume

0

Mkt Cap

3.48M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

18FebExpected

Q2 2024

Q2 2024

Q4 2024

Q1 2025

Q2 2025

Q4 2025

-0.81

-0.7

-0.58

-0.46

Expected EPS

-0.464317102546148

Actual EPS

N/A

Financials

-737.48%Profit Margin

Unprofitable

2019

2020

2021

2022

2023

2024

13.94MRevenue

-102.79MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Edwards Lifesciences

Edwards Lifesciences is a leading developer of heart valve systems and repair products, directly competing with Carmat's artificial heart technology.

Medtronic is a global leader in medical technology, services, and solutions, including cardiac and vascular products, making it a competitor in the artificial heart and heart valve market.

Abbott Laboratories

Abbott Laboratories offers a wide range of cardiovascular devices, including heart pumps and artificial valves, competing with Carmat's heart solutions.

Boston Scientific

Boston Scientific Corporation specializes in medical devices used in interventional medical specialties, including cardiac intervention products that compete with Carmat's offerings.

Stryker Corporation is involved in medical technologies, including surgical equipment and neurovascular products, indirectly competing with Carmat in the broader medical device market.

Johnson & Johnson

Johnson & Johnson, through its medical devices segment, competes in the cardiovascular and orthopaedic market, indirectly competing with Carmat's artificial heart technology.

Zimmer Biomet Holdings, Inc. specializes in musculoskeletal healthcare but its involvement in surgical products places it as an indirect competitor in the medical device market.

Intuitive Surgical

Intuitive Surgical, Inc. specializes in robotic-assisted surgery systems, indirectly competing with Carmat by offering alternative surgical solutions and innovations in healthcare.

Baxter International

Baxter International Inc. provides a broad range of hospital and renal products, including devices for cardiovascular diseases, making it an indirect competitor.

LivaNova PLC is a global medical technology company specializing in cardiovascular and neuromodulation products, directly competing with Carmat in the heart device market.

About

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

Show more...

CEO

Mr. Stephane Piat

Employees

153

Country

France

ISIN

FR0010907956

Listings

0 Comments

Share your thoughts

FAQ

What is Carmat stock price today?▼

The current price of ALCAR.PA is €0.10 EUR — it has decreased by -1% in the past 24 hours. Watch Carmat stock price performance more closely on the chart.

What is Carmat stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Euronext Paris exchange Carmat stocks are traded under the ticker ALCAR.PA.

Is Carmat stock price growing?▼

ALCAR.PA stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Carmat has showed a -19.9% decrease.

What is Carmat market cap?▼

Today Carmat has the market capitalization of 3.48M

What is Carmat revenue for the last year?▼

Carmat revenue for the last year amounts to 13.94M EUR.

What is Carmat net income for the last year?▼

ALCAR.PA net income for the last year is -102.79M EUR.

How many employees does Carmat have?▼

As of September 04, 2026, the company has 153 employees.

In which sector is Carmat located?▼

Carmat operates in the Health & Wellness sector.

When did Carmat complete a stock split?▼

Carmat has not had any recent stock splits.

Where is Carmat headquartered?▼

Carmat is headquartered in Vélizy-Villacoublay, France.